| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |